A new genetic technology has the potential to cure diseases and boost plant, insect, and human lives, but it also poses profound ethical questions.

Policymakers must act swiftly post-election to approve a viable fiscal plan or trigger market volatility and severe damage to the U.S. economy, writes CFR’s Robert Kahn.

The president’s annual address set the stage for more political wrangling over U.S. fiscal policy at a time when decisiveness is crucial for the economy, writes CFR’s Robert Kahn.